ACADIA Pharmaceuticals Statistics

Total Valuation

LON:0A4W has a market cap or net worth of GBP 2.68 billion. The enterprise value is 2.21 billion.

Market Cap	2.68B
Enterprise Value	2.21B

Important Dates

The last earnings date was Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	166.39M
Shares Outstanding	n/a
Shares Change (YoY)	+1.32%
Shares Change (QoQ)	+0.58%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	115.01M

Valuation Ratios

The trailing PE ratio is 15.12 and the forward PE ratio is 48.40.

PE Ratio	15.12
Forward PE	48.40
PS Ratio	3.47
PB Ratio	4.52
P/TBV Ratio	5.34
P/FCF Ratio	23.32
P/OCF Ratio	23.24
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.50, with an EV/FCF ratio of 19.28.

EV / Earnings	12.50
EV / Sales	3.00
EV / EBITDA	26.50
EV / EBIT	33.78
EV / FCF	19.28

Financial Position

The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.07.

Current Ratio	2.88
Quick Ratio	2.63
Debt / Equity	0.07
Debt / EBITDA	0.50
Debt / FCF	0.38
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 37.24% and return on invested capital (ROIC) is 8.21%.

Return on Equity (ROE)	37.24%
Return on Assets (ROA)	5.56%
Return on Invested Capital (ROIC)	8.21%
Return on Capital Employed (ROCE)	10.65%
Revenue Per Employee	1.18M
Profits Per Employee	270,876
Employee Count	654
Asset Turnover	1.00
Inventory Turnover	9.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-31.17%
50-Day Moving Average	17.41
200-Day Moving Average	16.42
Relative Strength Index (RSI)	58.25
Average Volume (20 Days)	2,167

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.29

Income Statement

In the last 12 months, LON:0A4W had revenue of GBP 771.11 million and earned 177.15 million in profits. Earnings per share was 1.06.

Revenue	771.11M
Gross Profit	460.65M
Operating Income	68.39M
Pretax Income	204.99M
Net Income	177.15M
EBITDA	78.69M
EBIT	68.39M
Earnings Per Share (EPS)	1.06

Full Income Statement

Balance Sheet

The company has 527.53 million in cash and 43.35 million in debt, giving a net cash position of 484.19 million.

Cash & Cash Equivalents	527.53M
Total Debt	43.35M
Net Cash	484.19M
Net Cash Per Share	n/a
Equity (Book Value)	592.29M
Book Value Per Share	3.54
Working Capital	439.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 115.30 million and capital expenditures -404,797, giving a free cash flow of 114.89 million.

Operating Cash Flow	115.30M
Capital Expenditures	-404,797
Free Cash Flow	114.89M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.74%, with operating and profit margins of 8.87% and 22.97%.

Gross Margin	59.74%
Operating Margin	8.87%
Pretax Margin	26.58%
Profit Margin	22.97%
EBITDA Margin	10.20%
EBIT Margin	8.87%
FCF Margin	14.90%

Dividends & Yields

LON:0A4W does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.32%
Shareholder Yield	n/a
Earnings Yield	6.61%
FCF Yield	4.29%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0A4W has an Altman Z-Score of 3.58.

Altman Z-Score	3.58
Piotroski F-Score	n/a